Download - Futurist Perspective
-
7/31/2019 Futurist Perspective
1/77
Futurist Perspectiveon the Implications
o ec no ogy orBehavioral Health &Social Services
David Whitehouse MDCMO Strate and Innovation
The 2009 Institute for Behavioral HealthInformatics:
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
Optum Behavioral Solutions The Future of Technology in Behavioral
Health
-
7/31/2019 Futurist Perspective
2/77
Medical andPharmaceutical
24% ($116.2M)
Indirect Medical CostsImpaired
Productivity
63% ($311.8m)Long-Term Disability
1% ($6M)
Absenteeism6% ($27M)
Short-Term Disability6% ($27M)
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
1
Copyright 2004 Harvard Business School Publishing Corporation. All rights reserved.Source: Bank One. Figures based on 2000 annual data. Workers compensation accounted for < 1% of indirect medical costs.
-
7/31/2019 Futurist Perspective
3/77
increase in overall sickness absence, particularly frequentshort periods of absence; poor health (depression, stress, burnout); physical conditions (high blood pressure, heart disease,
-, , , ,and backache, low resistance to infections).
Work performance reduction in productivity and output; increase in error rates; increased amount of accidents; poor decision-making; deterioration in planning and control of work.
Staff attitude and behavior
loss of motivation and commitment burnout staff working increasingly long hours but for diminishingreturns poor timekeeping labor turnover (particularly expensive for companies attop levels of management).
tension and conflicts between colleagues; poor relationships with clients; increase in disciplinary problems.
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
2
-
7/31/2019 Futurist Perspective
4/77
Work-related suicide
Overwork-related deaths, including suicides - karojisatsu areofficially recognised and compensated in Japan. Figuresreleased in May 2007 showed of the record 205 individuals inJapan qualifying for workers' compensation insurance payouts
in the 2006 fiscal year, 65 involved death by suicide and oneinvolved an attempted suicide, according to the Ministry of
Anthony McDermott, factory worker, 50Suicide verdict on bullied factory worker,Hazards news 11 Februar 2006
Health, Labour and Welfare. This was up from 42 work-relatedsuicides the previous year.
Wayne Williams, engineer, 28Suicide note blamed work pressure, Hazards news, 24 June 2006An en ineer who killed himself wrote in a suicide note sa in 'the ressure of
,
A father of four killed himself after beingbullied by his managers for two years, aninquest has heard. Anthony McDermott, 50,left a letter explaining his factory floorordeal before hanging himself. He workedfor the same firm for 14 years but the
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
3
work has turned my mind into a ticking time bomb,' Wayne Williams hangedhimself after a party to mark the end of a year-long contract in Singapore.
hearing was told that at the end he found abullying campaign soul destroying anddemeaning.
-
7/31/2019 Futurist Perspective
5/77
Co-Morbidity
% Co-Morbidity Increase in
Co-Morbidity with Medical Member Medical Cost
with Depression Medical Costs
Heart Disease
Cancer
35% 163%
30% 100%$4,000
$6,000
$8,000
,
$4,258
$2,977
$8,103
Cost ~ 5,000 More
Asthma
Diabetes
Hypertension
40% 183%
25% 109%
22% 103% TotalPo ulation
Non- Depressed
$0
$2,000
Stroke
Arthritis
35% 100%
25% 183%Average 28%Co-Morbidity
22% of Americans have some form
of diagnosable mental disorder
9.5% of the population is affected bydepression in any given year
Sources: Census Bureau Current Population Survey, CMS,
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
4
treated according to minimum standards
Kaiser Family Foundation, EBRICDC; Milliman; U.S. Dept. of Health & Human Services,SAMHSA; ChapterHouse,
-
7/31/2019 Futurist Perspective
6/77
Brain differences associated with depression
Area 25 altered metabolism and 39% (bipolar)
Mental disorders as brain disorders
,
Cg25
Brain Resource l enabl ing opt imal so lu t ions for bra in heal th l www .bra inresource.com
Drevets et al., Nature, 1997Brain Resource l enabl ing opt imal so lu t ions for bra in heal th l www .bra inresource.com
Progressive Brain Structural Changes Mapped as
Psychosis Develops in At Risk Individuals
200520062007 first quarter2007 second quarter2007 third quarter2007 fourth quarterFebruary 2008
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
5
Brain Resource l enabling opt imal solut ions for brain health l www.brainresource.com
Sun et al, Schiz Res., 2008Brain Resource l enabling opt imal solut ions for brain health l www. b r a in r e s o u r c e . c o m
Manolio, Brooks, Collins, in press.
-
7/31/2019 Futurist Perspective
7/77
Looking Beyond ECT, Meds or Therapy
St. Jude Medical AcquiresNorthstar NeuroscienceAssets for $2 Million
TMS
CSS
On June 8, 2009, St. JudeMedical, Inc., acquiredNorthstar Neuroscience,Inc.s intellectual propertyportfolio, clinical study data,device designs, and
Northstars Renova Cortical Stimulation System*Medical College of Wisconsin, MilwaukeeI
manu ac ur ng equ pmenfor $2 million. Northstarfocused on developingcortical stimulationtherapies for the treatmentof major depressivedisorder stroke and other
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
6
6
University of Pittsburgh, Pittsburgh
Massachusetts General Hospital, Boston
, ,neurological disorders..
-
7/31/2019 Futurist Perspective
8/77
STAR*D
Largest U.S. study of Major Depression 3,671 patients over one year.
No medication better than another.
= , . ,
More than one med = more likely to relapse
Rush, J. American Journal of Psychiatry. 2006; 163:1905-17.
STAR*D Clinical Study ResultsRelapse Rates (QIDS-SR )16 >_11
Level1 Level2
(1 Failure)
Level3
(2 Failures)
Level4
(3 Failures)
Level1 Level2
(1 Failure)
Level3
(2 Failures)
Level4
(3 Failures)1-9 Weeks 8-10 Weeks 14 Weeks
-
7/31/2019 Futurist Perspective
9/77
Methods and FindingsWe obtained data on all clinical trials submitted to the US Food and Drug Administration (FDA)for the licensing of the four new-generation antidepressants for which full datasets were
-.initial severity on improvement scores for drug and placebo groups and on drugplacebodifference scores. Drugplacebo differences increased as a function of initial severity, risingfrom virtually no difference at moderate levels of initial depression to a relatively smalldifference for patients with very severe depression, reaching conventional criteria for clinicalsignificance only for patients at the upper end of the very severely depressed category. Meta-regression analyses indicated that the relation of baseline severity and improvement wascurvilinear in drug groups and showed a strong, negative linear component in placebo groups.
Conclusions
severity, but are relatively small even for severely depressed patients. The relationshipbetween initial severity and antidepressant efficacy is attributable to decreasedresponsiveness to placebo among very severely depressed patients, rather than toincreased responsiveness to medication.
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
8
-
7/31/2019 Futurist Perspective
10/77
WIRED MAGAZINE: 17.09Med-Tech : Drugs
RX FOR SUCCESSWhat turns a dummy pill into a catalyst for relieving pain, anxiety,
depression, sexual dysfunction, or the tremors of Parkinson's disease? The
Placebos Ar e Ge t t in g
Mo r e Effect ive .
D r u gm a k e r s Ar e
brain's own healing mechanisms, unleashed by the belief that a phonymedication is the real thing. The most important ingredient in any placebois the doctor's bedside manner, but according to research, the color of atablet can boost the effectiveness even of genuine medsor help convince apatient that a placebo is a potent remedy.Steve Silberm an
Yellow p ills
D e sp e r a t e to Kn o w W h y.By Steve Silberman
Red pi l ls
can give you a more stimulating kick. Wake up, Neo.
make the most effective antidepressants, like littledoses of pharmaceutical sunshine.
e a e sparticularly those labeled "antacid"are superior forsoothing ulcers, even when they contain nothing butlactose.
The co lo r g r een
M o r e i s b e t t e r ,
scientists say. Placebos taken four times a day delivergreater relief than those taken twice daily.
re uces anx e y, a ng more c o e p .
B r a n d i n g m a t t e r s .
Placebos stamped or packaged with widely recognizedtrademarks are more effective than "generic" placebos.
Cl eve r na m es
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
9
can add a placebo boost to the physiological punch in realdrugs. Viagra implies both vitality and an unstoppableNiagara of sexy.
-
7/31/2019 Futurist Perspective
11/77
CATIE Stud of Anti-Ps choticsLargest and longest study of its kind
Over 1,400 patients with schizophrenia
18 months: Tolerability and Efficacy
Efficacy and Tolerability: poor
CATIE Study Phase 1:74% stopped meds for anyTime to Discontinuation for Any Cause
Olanzapine (N=330) Risperidone (N=333)
Ziprasidone (N=183)
Quetiapine (N=329)Perphenazine (N=257)
0.9
1.0
tients
men
t
reasonSubstantial side effects: 64%
to 70%.
0.7
0.6
0.4
0.3
0.5
ProportionofPa
ContinuingTreaRegular Antipsychotics fared as
well as Atypicals
18Lieberman JA et al. N Engl J Med. 2005;353:1209-1223.
0.1
.
0.00 3 6 9 12 15 18
Time to Discontinuation for Any Cause (months)
Stroup, T and McEvoy, J. AmericanJournal of Psychiatry2006, 163: 600-622
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
10
-
7/31/2019 Futurist Perspective
12/77
The Current situation
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
11
-
7/31/2019 Futurist Perspective
13/77
Many Treatments Ineffective for Many
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
12
-
7/31/2019 Futurist Perspective
14/77
Pharmacogenetics
The death of nine-year-old MichaelAdams-Conroy didn't seem at first likea si nal event in medicine. It seemed
or une agaz ne c o er ,
like homicide.
While recuperating from whatseemed to be flu, Michael went into a
.His grieving parents, Jayne and Neil,soon got another shock: an autopsyshowed a massive overdose of Prozac
in Michael's blood and tissues, raisingthe specter of a murder chargeagainst them
- '
CYP2D6 gene deletion occurs in 6% ofCaucasians and CYP2D6 gene duplicationoccurs in 30% of East AfricansCYP2D6 metabolizes a broad array of
painful pilgrimage to a medical frontier
known as pharmacogenetics, thestudy of how genetic idiosyncrasies
drugs, from cough suppressants toantidepressantsIn Michaels case CYP2D6 gene deletioncaused fluoxetine to build up in his body
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
13
influence responses to drugs to a level exceeding any previouslyreported in cases of Prozac overdose
-
7/31/2019 Futurist Perspective
15/77
Differences in Metabolism
Schizophrenia: Abilify
ADD: Atomoxetine
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
14
-
7/31/2019 Futurist Perspective
16/77
The truth is.
healthcare professionals to deliver patient carewi h h ffi n i n n f h
the full range of current knowledge couldsupport.
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
15
-
7/31/2019 Futurist Perspective
17/77
Personalized Medicine Why do we need it?
Successful When it Leads to Innovation
Old Paradigm: Trial and Error Medicine
an mproves an ar o are.
Fails When We Settle for Trial andError Medicine as theStandard of
Care.
STAR-D
Largest U.S. study of Major Depression 3,671.
No medication better than another.
37% remission after 1 trial, 67% after 4.(Massive dropout rates = 21, 30 and
More than one med = more likely to relapse
Rush, J. American Journal of Psychiatry. 2006; 163:1905-17.
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
16
-
7/31/2019 Futurist Perspective
18/77
The future is nowC H A P T E R 2Neuroscience Research Agendato Guide Development of aPathophysiologically Based
eurosc encebrings a newri or and
Dennis S. Charney, M.D., David H. Barlow, Ph.D.,Kelly Botteron, M.D., Jonathan D. Cohen, M.D.,David Goldman, M.D., Raquel E. Gur, M.D., Ph.D.,Keh-Min Lin M.D. M.P.H. Juan F. L ez M.D.
insight intoMH
James H. Meador-Woodruff, M.D., Steven O. Moldin,Ph.D., Eric J. Nestler, M.D., Ph.D., Stanley J.Watson, M.D., Ph.D., Steven J. Zalcman, M.D.
.perhaps the greatest promise for the field lies in the combined use of the variousmethods. There are a variety of benefits that can be gained by the integrated useof different modalities, many of which are beginning to be explored.
,identifying intermediate phenotypes related to the patients genotype and behavioralphenotype. The neurobiological phenotype may be discerned by neuroimaging,
cognitive evaluation, and neurophysiological testing. The neurobiological phenotype
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
17
monitoring the neurobiological response to treatment
-
7/31/2019 Futurist Perspective
19/77
How neuroscience changes assessment
Dont just ask people how they feel, measure the brain inaction
Analogous to a cardiac stress test
You use a standard assessment of general plussocial cognition - to measure brain efficiencies
By simulating real world challenges, you canidentify the strengths and weaknesses that
characterize each individual brain B com arin those results to matched controls
in a database, you can reliably identifysignificant differences
Brain Health Strategies decision support ruleshelp link each clients Markers to their best
personalized solution
But brain tests and genetic tests by themselves are
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
18
expensive, complex, not easily accessible
-
7/31/2019 Futurist Perspective
20/77
BRID: neuroscience power behind Optum Brain
Integration
Standardization
insights that arepossible onlywhen there is a
Brain ResourceInternational Database
huge databasewith
INTEGRATED
Linking Markers to SolutionsThese are: the most complicated aspects of data
andSTANDARDIZEDdata
Independent Scientific
the source of the clinical power of theassessmentthe critical element in the difficulty for
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
19
-
7/31/2019 Futurist Perspective
21/77
IntegrationBrings together measures of genomics, brain, cognition and experience thatare normally assessed in isolation.
Genomics
Brain
Cognition Experience
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
20
-
7/31/2019 Futurist Perspective
22/77
NIH and NIMH Databases
WWW Available Human Databases
dbGaP
Genotype and Phenotype http://www.ncbi.nlm.nih.gov
--3/2008
Linked Efforts to Accelerate Parkinson's Solutions (LEAPS)
Linking Genome Wide Association Study of Schizophrenia8/2008
Major Depression: Stage 1 Genome wide Association in
Population-Based Samples7/2008
NEI Age-Related Eye Disease Study
' va a e uman a a ases
http://hendrix.imm.dtu.dk/services/jerne/brede/ Brede database/ Data from fMRI scientific articles containing
Talairach coordinates
http://www.fmridc.org/f/fmridc Peer reviewed repository of fMRI studies and their underlying data
- -
NINDS Repository Neurologically Normal Control Collection Whole Genome Association Study of Bipolar Disorder
7/2008 http://www.pdgene.org/
Parkinson's disease genetic association studies
http://www.ncbi.nlm.nih.gov/SNP/
NCBI Single Nucleotide Polymorphism http://www.nbirn.net/bdr/index.shtm
ey are ne er astandardized or
integrated p: ase.org cg - n we come.cg A community website for Huntington's Disease (HD) research
http://www.hprd.org/ Human Protein Reference Database. Centralized platform to visually
depict and integrate information pertaining to domain architecture,post-translational modifications, interaction networks and diseaseassociation for each protein in the human proteome
http://132.183.217.124/brainbank/Main
National Brain Databank: Brain Tissue Gene Expression Repository.
Biomedical Informatics Research Network (BIRN) Data Repository.Biomedical imaging data from humans and animal models areavailable for download with descriptive metadata, and in some cases,associated clinical, microarray, or other biomedical data.
Gene expression data from microarray experiments on brain tissue
samples, along with diagnostic results from postmortem studies ofneurological and psychiatric disorders http://arrayconsortium.tgen.org/np2/home.do
NIH Neuroscience Microarray Consortium http://mecp2.chw.edu.au/
RettBASE: IRSA MECP2 Variation Database. Mutation andpolymorphism data from the published literature pertaining to Rettsyndrome and related clinical disorders
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
21
-
7/31/2019 Futurist Perspective
23/77
Brain Resource International Database
1. All these measures are taken ineach individual in the core database.1. All these measures are taken ineach individual in the core database.
Depression; Conduct DisorderSchizophrenia Eating DisordersPTSD Sleep DisordersADHD Panic Disorder
ement as p epsyMultiple Sclerosis HIV/AIDS
Head Injuries
2. In thousands of normals.2. In thousands of normals.
3. And in a spectrum ofclinical groups.3. And in a spectrum ofclinical groups.
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
22
e ata ase nc u es over 20,000 atasetsIt covers 6-100 years of age.
It includes sites in the USA, Europe, Africa and Australasia.
-
7/31/2019 Futurist Perspective
24/77
-
7/31/2019 Futurist Perspective
25/77
Screening and Assessment
BRISC: Brain Resource Inventor of Social Co nition10- 15 minute test identifying social cognition, depression,
anxiety and stress.
BRISC provides a sensitive, yet rapid and cost-effective screening to prioritizehigher risk individuals, saving time and money.
DemographicDetails
DASS Scale:De ression
EmotionalIntelligence
Personality
Anxiety
Stress
BRISC indicates if an individual is at risk per3 critical numbers
A new approach to screening that goesbeyond diagnosis specific instruments tocapture a brain at risk whatever thediagnosis; quantifies the distress and
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
2424
Negativity BiasSocial Skills
Emotional Resilience
helps by highlighting unique strengthsand vulnerabilities
-
7/31/2019 Futurist Perspective
26/77
Detailed, Personalized Informationon Functional Difficulties, Strengths
A true functional assessment that not onlyrelates to real world issues; but establishespersonalized markers that can guide
an ea nesses
30-45 minute Web-based tool that measures social and generalcognition covering cognitive domains including: memory,
unique specific interventions
a en on, sensory-mo or s s, execu ve unc on, mpu s v y,and emotional recognition.
Motor tapping Digit SpanRecognitionMemory
Choice reactiontime
Verbalinterference
EmotionRecognition
Press Dpress
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
25
Switching ofattention
Executivemaze
SustainedAttention
Emotion RecognitionRecallGo No Go
Delayed Memoryrecognition
-
7/31/2019 Futurist Perspective
27/77
Social Cognition A powerful addition to
nce arw nEmotional responses = inheritedpatterns of behavior shaped by
adaptation.Facial expressions of emotion have
remnants of previous adaptivebehavior, persisting in mild form.
-support for basic emotions and theirfacial expression
, , , ,
sadness, and surprise
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
26
-
7/31/2019 Futurist Perspective
28/77
Depression: General Cognitive Markers
Response Speed Depression What Depression
Attention-Concentration
Memory
Impulsivity Depression Profile
Info Processing Efficiency
Executive Function
-2 -1.5 -1 -0.5 0
Emotion Recognition
-4 -3 -2 -1 0-4 -3 -2 -1 0-4 -3.5 -3 -2.5 -2 -1.5 -1 -0.5 0
Depression: Soc ial Cognitive Markers
-4 -3.5 -3 -2.5 -2 -1.5 -1 -0.5 0 0.5 1
Negativity BiasNegativity Bias
Emotional Resilience
Emotional Res i l ience
Sociability
Depression
Social SkillsSocial Skills
Neg ativity Bias
Emot ion: Sadness Speed
Assessing strengths andweaknesses and identifying
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
27
Brain Resource 2008 27
-8 -6 -4 -2 0Emotion: SadnessAccuracy
-
7/31/2019 Futurist Perspective
29/77
Combo of general/social cognition separates
1. HypoprocessingDepression Subtypes
ty-Inhib
itio
0.0
2.5
1
2
2. HyperprocessingAnxiety
+Impulsivi
-2.5
roupCentroid
FearRT
-7.5
-5.0
-5.0 0.0 2.5-2.5 5.0
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
28
a an ega v y as
-
7/31/2019 Futurist Perspective
30/77
These marker indicators also predict different categories:
SSRI with Hyperprocessing,
SNRI with Hypoprocessing
Tric with Mixed
Med_type2.5
.
2. SNRI
3. TriCFea
rRT
0.0
1
2
Group Centroid
-5.0
-2.5
3
-2.5 0.0 2.5
91.8%
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
29
VigilanceAttentionResponse Speed
-
7/31/2019 Futurist Perspective
31/77
-
7/31/2019 Futurist Perspective
32/77
When people get depressed their brains react in different ways:Knowing this has implications in how best to help themPredispositions: Genomic; Neuroticism; Negativity Bias; Stress
Hyperprocessing No Adaptive Compromise Hypoprocessing
EEG Beta
Nonconscious ERPautomatic bias to emotion
processing
EEG Coherence measures
Variability of all responses
Emotion Regulation
EEG Theta: Alpha
Conscious ERP emotionprocessing
Motor response speed
Startle EMG
ANS Arousal
Right Hemisphere
fMRI Amygdala ACC
SymmetryfMRI Amygdala ACC
Medial Frontal
ANS Arousal
Memory, attention,planning
Left Hemisphere
Markers
Medial Frontal
Cortex
Limbic Cortical Tone:
SSRI
TriC higher dose SNRI
Stabilize Limbic Cortical Tone: SNRI
Limbic Cortical Tone:
volume Lateral FrontalCortex
Treatment
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
31
Source: Williams & Gordon, The Neuroscientist, 2007.
-
7/31/2019 Futurist Perspective
33/77
The Texas Algorithm and STAR-D
Builds on the bestalgorithms and enhances
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
32
-
7/31/2019 Futurist Perspective
34/77
BRC advantages at step one
Initial drug selection in STAR-D is just citalopram in the Texas Algorithm itcould be SSRIs, Bupropion SR, Venlafaxine XR, Mirtazapine, orNefazadone, but there is no guidance for selection of a particular agent.
Treatment success at the first step is less than 50% with high drop out ratesand non-adherence.
Using web based neuropsychology tests backed by an integrated databasewhich is normed and age and education matched to create better
understanding of the probable endophenotype at a personalized level, while an individual level for a specific agent can significantly increase the likelihoodof a successful step one match increasing the chance of a faster moreacceptable response, greater adherence and decreased costs from possibly
.
In this regard BRC is complimentary to the Texas Algorithm AND makes iteven more useful by creating an easy to use decision support for step one.
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
33
-
7/31/2019 Futurist Perspective
35/77
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
34
-
7/31/2019 Futurist Perspective
36/77
No medicationtriggered
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
35
35
-
7/31/2019 Futurist Perspective
37/77
Urgent risk(caseidentification)
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
36
36
-
7/31/2019 Futurist Perspective
38/77
ons stent
with selfreportedde ression-anxiety-stress
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
37
37
-
7/31/2019 Futurist Perspective
39/77
But, no
Thinking Emotionmarkers formedication
.
Or, for othercognitive
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
38
38
problems
-
7/31/2019 Futurist Perspective
40/77
But there is aSelf Regulationmarker forpoor emotionalres ence.
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
39
39
-
7/31/2019 Futurist Perspective
41/77
Case 1 Summary
Urgent Risk case identification
No Thinking/Emotion markers indicating a biologicalalteration, or other cognitive problem
= indicates psychotherapy (like CBT)*.
Self Regulation marker present (poor emotional resilience)
= Confirms likely value of psychotherapy (like CBT)
*
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
40
.
40
-
7/31/2019 Futurist Perspective
42/77
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
41
41
-
7/31/2019 Futurist Perspective
43/77
Example of use of BR methodology
The Database provides a frame of reference for better quantification of the
Drug X may cause a significant change in the DV, however only drug Y shows achange that is clinically meaningful
p =
-
7/31/2019 Futurist Perspective
44/77
Wh are we so reluctant to incor orate the im lications?
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
-
7/31/2019 Futurist Perspective
45/77
The Implications of a Brain that canchange itself.
Can we train and develop the
cognitive brain?
n an age o now e ge wor erscould this hold the competitive
e ge
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
44
-
7/31/2019 Futurist Perspective
46/77
Cajal: At the start of the 20th century Cajalproposed that brain cellsunlike every othercell in our bodydont divide. They dont die,
.
the womb with the only brain we willever have.
Pasko Rakic, the chairman of Yale Universitysneurobiology department was the most convincing moderndefender of this theory. All neurons of the rhesus monkeybrain are enerated durin re-natal and earl ost-natal
life, Rakic wrote in his 1985 paper, Limits ofNeurogenesis in Primates. Not a single newneuron was observed in the brain of any adult
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
45
animal.
-
7/31/2019 Futurist Perspective
47/77
Fernando Nottebohm
Showed that songbirds, in order to survive andcreate new songs, added at least 1% of new tissueto their song centers each day
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
46
J h Alt 1962 MIT h d h i h b
-
7/31/2019 Futurist Perspective
48/77
Science30 March 1962:vol. 135. no. 3509 . 1127-8
Joseph Altman: 1962 MIT suggests the accepted truths might be wrong.
Are New Neurons Formed in the Brains of Adult Mammals?In an autoradiographic investigation, the production of brain lesions in rats was combinedwith intracranial injection of thymidine-H3. Inaddition, some neurons and neuroblastsshowed labelin su estin the ossibilit of roliferation of neurons in adult rats
Michael Kaplan: 1977 The University of New Mexico
The electron microsco ic observations re orted in this stud reveal: I that a steadrate of granule cellneurogenesisoccurs during the first year of a rodents life; (2) thatnewly formed granule neurons in the dentate gyrus of the newborn mouse and adult ratare a result of neuroblast division; and (3) two distinct classes of mitotic cells can beidentified during the peak period of postnatal neurogenesis-those with synapses ontheir cell bodies and processes and those with no synapses or processes.
Rakic told him They may look like neurons in New Mexico but they dont inNew Haven
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
47
Eli b th G ld P i t
-
7/31/2019 Futurist Perspective
49/77
Elizabeth Gould: Princeton
In 1989 Gould while looking at rat brain degeneration in rats
following glucocorticoid administration found that the brain alsohealed itself
, -Early life experience alters response of adult neurogenesis to stressChristian Mirescu, Jennifer D Peters & Elizabeth Gould
.post-doc, Mirescu, they deprived newborn rats of their mother for either 15 minutes orthree hours a day. Earlier studies had shown that even after these rats become adults, theeffects of their developmental deprivation linger: They never learn how to deal with stress.
.
from the stress response. But these deprived rats cant do that. Its as if they are missingthe off switch. The rat might have forgotten its pain, but its brain never did. Pre-nataltrauma also has life-long implications. Being low in a dominance hierarchy also
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
48
. .thumb, a rough lifeespecially a rough start to lifestrongly correlates with lower levelsof fresh cells.
Ronald Duman: Yale
-
7/31/2019 Futurist Perspective
50/77
Ronald Duman: Yale
demonstrating that antidepressants increased neurogenesis in the
adult rat brain. In fact, the two most effective treatments they lookedatelectroconvulsive therapy and Prozac increased neurogenesis in
, .the exact same molecules, especially trophic factors, that are suppressed by stress.
Luca Santarelli: Columbia
-
Requirement of Hippocampal Neurogenesis for theBehavioral Effects of AntidepressantsLuca Santarelli,1* Michael Saxe,1* Cornelius Gross,1Alexandre Surget,2 Fortunato Battaglia,3 Stephanie Dulawa,1Noelia Weisstaub,1 James Lee,1 Ronald Duman,4 Ottavio
Arancio,3 Catherine Belzung,2 Ren Hen1 .
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
49
. ere, us ng gene c an ra o og ca me o s, we s ow a srup ng antidepressant-induced neurogenesis blocks behavioral responses to antidepressants
-
7/31/2019 Futurist Perspective
51/77
A new paradigm
The partially
The
The brokenThe breakingeve opebrain
healthy brain
brainstressed brain
Every day your cognitivebrain is hostage to youremotional brain
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
50
-
7/31/2019 Futurist Perspective
52/77
Taking Care of the Brain
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
51
-
7/31/2019 Futurist Perspective
53/77
Nutrition, Exercise and the Brain
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
52
-
7/31/2019 Futurist Perspective
54/77
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
53
-
7/31/2019 Futurist Perspective
55/77
Its a whole new world
Train the BrainFrom The Times
Januar 26, 2009
Nintendo brain-trainer 'no better than pencil and paper'
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
54
A Wh l N G i Of G
-
7/31/2019 Futurist Perspective
56/77
A Whole New Generation Of Games
from Uncle Milton
Mindflex from mattel
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
55
M B i S l ti
-
7/31/2019 Futurist Perspective
57/77
MyBrainSolutions
-
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
56
. .which draws on new insights to develop better brain habits
-
7/31/2019 Futurist Perspective
58/77
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
57
57
My Brain
My Brain
-
7/31/2019 Futurist Perspective
59/77
These are your average scores for: Emotion-Thinking-Feeling-Self Regulation.
DisclaimerThis report provides indications of general cognition and social cognition as compared directly or indirectly to a normative database. It is not to be used as a basis for actionwithout consideration by a competent relevant professional. Always seek the advice of a trained health professional or relevant specialist regarding any highlighted varianceswithin this report before any treatment or action is taken. This report is not intended to be used in any way on its own to diagnose, select treatment or cure any health
ee age to v ew recommen e ra n ra n ng rograms ase on your ra n core pro e.
See Page 3 and 4 to view the explanation and details of your scores.See Page 5 to read about the theoretical brain model which underlies these scores.
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
58
con on. s repor oes no es a s any p ys c an-pa en re a ons p or supp an any n-person me ca consu a on or exam na on. ppropr a e me ca a en on s oualways be sought for specific ailments. Do not disregard professional medical advice or delay seeking medical treatment as a result of findings contained within this report.Brain Resource expressly disclaims any and all responsibility for any liability, loss or risk which may be or is incurred as a consequence, directly or indirectly, of any use andapplication of this report.
Educate Motivate Set Goals
-
7/31/2019 Futurist Perspective
60/77
Educate, Motivate, Set Goals
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
59
Engage With Solutions
-
7/31/2019 Futurist Perspective
61/77
Engage With Solutions
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
60
On-line Cognitive Therapy
-
7/31/2019 Futurist Perspective
62/77
On line Cognitive Therapy
Not just a rich knowledge base,but smart tools and programs
,therapy, journaling, coaching and
prevention. Embedded screeninglogic - tools adjust to member.
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
61
Heart Rate VariabilityThe Connection
-
7/31/2019 Futurist Perspective
63/77
Heart Rate VariabilityThe Connection
You have a personalized BEST BREATHING
RATE,
or Resonant Frequency,
en you are rea ng a
your Resonant Frequency,your heart and brain areworking together in
synchrony and you are calm,
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
62
w ere your o y s a gne or pea per ormance.focused and
in the zone.
MyCalmBeat: How it Works
-
7/31/2019 Futurist Perspective
64/77
MyCalmBeat: How it Works
Low heart rate variability (and faster breathing)has been connected to worry and negativefeelin s ain and stresses at work 1-3 .
Higher heart rate variability enables people torecover more easily from stress, and boost theirositive feelin s 2 .
Higher heart rate variability is also beneficial toour ability to focus and concentrate, and to
.
1)Princi T, Accardo A and Peterec D. (2004).
2)Thayer J and Lane RD. (2000).
3)Pieper S, Brosschot JF, van der Leeden R, Thayer JF. (2007).
4)Porges S. (1992).
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
63
Integrates with MyBrainSolutions
-
7/31/2019 Futurist Perspective
65/77
Integrates with MyBrainSolutions
As a registered user ofwww.mybrainsolutions.com,
use the MyCalmBeat
.Set the breathing bar to
your Resonant Frequency.
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
64
Human Capital Solutions
-
7/31/2019 Futurist Perspective
66/77
Human Capital Solutions
Much more than managing the sickness business post eventum
Beyond sickness management to wellness and prevention (EAP/WL);
Beyond wellness and prevention to optimization (Resiliency training, social skillstraining etc,)Beyond individual optimization to team and group capability maximization;Beyond team optimization to corporate culture productivity maximization
Technomedia Partners With SBT to Accelerate Its
International ExpansionMontreal Nov. 28Technomedia, a Canadian provider of talent managementand human capital development solutions, announced itspartnership with the SBT (Scientific Brain Training) group, aEuropean provider of training and evaluation of cognitive
.portfolio and international presence through the signature of
a letter of intent to acquire Technomedia, which will enterinto effect in mid-December. For its part, Technomedia willround out its TM SIGAL technology and e-learning servicesb offerin su ort for the behavioral and co nitive
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
65
assessment of employees.
Neuroleadership
-
7/31/2019 Futurist Perspective
67/77
Neuroleadership
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
66
EducationNBER WORKING PAPER SERIES
THE ECONOMICS, TECHNOLOGY AND
-
7/31/2019 Futurist Perspective
68/77
Education CO O CS, C O OG
FORMATIONJames J. Heckman; Working Paper 13195;http://www.nber.org/papers/w13195NATIONAL BUREAU OF ECONOMIC RESEARCH1050 Massachusetts AvenueCambridge, MA 02138
Fifth, for both animal and human species, there is compelling evidence of.
readily acquired at certain stages of childhood than other traits (Knudsen et al.,2006). For example, on average, if a second language is learned before age12, the child speaks it without an accent (Newport, 1990). If syntax and
grammar are not acquired early on, they appear to be very difficult to learnlater on in life (Pinker, 1994). Different types of abilities appear to bemanipulable at different ages. IQ scores become stable by age 10 or so,suggesting a sensitive period for their formation below age 10 (Schuerger andWitt, 1989). There is evidence that adolescent interventions can affect
., .neuroscience that establishes the malleability of the prefrontal cortex into the
early 20s (Dahl, 2004). This is the region of the brain that governs emotion andself-regulation. Rutter (2006) and Rutter et al. (2006) present comprehensivesummaries of age-dependent epigenetic and other gene-environment
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
67
nteract ons or psyc opat o ogy nc u ng aggress on. n average, t e aterremediation is given to a disadvantaged child, the less effective it is.
Focused Strategy
-
7/31/2019 Futurist Perspective
69/77
gy
Mild Cognitive ImpairmentAlzheimer's DiseaseChemobrain (Emotional andcognitive deficits following
chemotherapy)SchizophreniaHIVLyme Disease
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
68
Neuroscience in Sports Medicine
-
7/31/2019 Futurist Perspective
70/77
p
Emerging Evidence and Conclusions based on data derived from CarlstedtSubliminal Attention, Reactivity, Coping Scale-A includes:Model Explained up to 50% of the Variance in Performance
qua on, ncreas ng near y as a unc on o eve o r ca yRelative Trait and State Left Brain Hemispheric Predominance Predicted
Performance on the basis of Objective Longitudinal Outcome MeasuresDynamics of Isolated Measures in Predicting Performance are Reconcilablewith Brain Localization and Functional Studies of these Traits/Behaviors(incl. Dietrichs Transient Hypofrontality Hypothesis) and EEGinvestigations of AthletesALL ATHLETES SHOULD BE ASSESSED ON THE ABOVE MEASURES* THEY ARE POTENT PREDICTORS OF AN ATHLETE'S
COMPETITION!
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
69
Use of Neuroscience to Drive Marketing
-
7/31/2019 Futurist Perspective
71/77
Pharmaceutical (physicians, patients, pharmacists, caregivers& nurses)
Pfizer GlaxoSmithKline Merck
Sanofi-Aventis Novartis AstraZeneca
Genentech (Ortho McNeil, Janssen& Scios)
Boehringer Ingelheim
Schering PloughSolvay BiogenIdec
Brain Surgery Offers 3 "Connection"ProductsCONNECTIONS BONDING
Abbott Adolor
Altana
EisaiShire KOS
emo ona m n se c us er ng, core n ng,Emotion Drivers, attribute/message testing
and final messaging)CONNECTION DRIVERS(emotional "mindset" clustering and Emotion
Wyeth Amgen Endo
Bayer Schering
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
70
CONNECTIONS TESTING(Emotion Drivers and testing)
Consumer and Business to Business
Nextel
2 0 P e r ce n t o f Scie n t is t s Ad m it U s in g
Br a in -En h a n cin Dr u s -- Do Yo u ?
-
7/31/2019 Futurist Perspective
72/77
Br a in En h a n cin Dr u s Do Yo u ?By Alexis Madrigal
Nature released the results of an online surveyin which 20 percent ofrespondents, largely drawn from the scientific community, admitted tousing brain-enhancing drugs like Ritalin (methylphenidate) and Provigil(modafinil).
Society must respond to the growing demand for cognitive enhancement.That response must start by rejecting the idea that 'enhancement' is a dirty
The Ultimate Cureby David Ewing Duncan May
, .
2008 Issue
The neurotech industry isengaged in a $2 trillion race tofix your brain. Many players will
Can everyone be an Einstein?
Science is getting ever closer tosolving the complex puzzle that isthe human brain. And its beginning
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
71
a , u e payo w e ugefor those who succeed.
usBryan Appleyard
Modafinil
-
7/31/2019 Futurist Perspective
73/77
solveproblem
1.6
1.8
Placebo
Low
High
* * **
P=0.002
ttemptstakento
correctly
1.0
1.2
1.4
rovement
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
72Number of moves
Mean
0.8
1 2 3 4 5 6
Modafinil improves planning inhealthy volunteers
Im
Militar uses of co nitive enhancers
-
7/31/2019 Futurist Perspective
74/77
Research and Development organisation for the US Department of Defence
Eliminating the need for sleep during an operation,while maintaining the high level of both cognitive and
h sical erformance of the individual will create afundamental change in war fighting and forceemployment. Such a capability has the potential todisrupt enemy OPTEMPO [operations tempo],
forces and shorten the duration of conflict.
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
73
Transcranial Direct Cortical Stimulation
-
7/31/2019 Futurist Perspective
75/77
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
74
-
7/31/2019 Futurist Perspective
76/77
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
75
It is estimated that 50% of the
-
7/31/2019 Futurist Perspective
77/77
will be obsolete in 6 years
NIMH sa s it takes 17 ears forinformation to get from research to
practice
Confidential property of OptumHealth. Do not distribute or reproduce without express permission of OptumHealth.
76